Provided by Tiger Trade Technology Pte. Ltd.

Akari Therapeutics PLC

10.14
-0.1100-1.07%
Volume:11.15K
Turnover:120.53K
Market Cap:19.74M
PE:-0.64
High:11.00
Open:11.00
Low:10.09
Close:10.25
52wk High:49.60
52wk Low:3.02
Shares:1.95M
Float Shares:694.50K
Volume Ratio:0.24
T/O Rate:1.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.9015
EPS(LYR):-20.5537
ROE:-140.09%
ROA:-19.10%
PB:1.06
PE(LYR):-0.49

Loading ...

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live
·
Sep 15

European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading

MT Newswires Live
·
Sep 10

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
Sep 09

European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading

MT Newswires Live
·
Sep 08

Akari Therapeutics to Present PH1 ADC Payload Platform at Oncology and Investor Conferences

Reuters
·
Sep 08

European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading

MT Newswires Live
·
Aug 31

Akari Therapeutics Participates in Virtual Investor “Why Now” On-Demand Conference Webcast

Reuters
·
Aug 27

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
Aug 26

European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading

MT Newswires Live
·
Aug 18

Akari Therapeutics - Ph1 Payload Shows Potential to Overcome Payload-Specific Resistance

THOMSON REUTERS
·
Aug 18

Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity in Urothelial Cancer Preclinical Models

THOMSON REUTERS
·
Aug 18

Akari Therapeutics - Continues to Advance Ind-Enabling Activities for Aktx-101 with Goal of Initiating Phase 1 Clinical Trial in Mid-2027

THOMSON REUTERS
·
Aug 18

Akari Therapeutics - Developing Aktx-102 ADC Targeting Ceacam5 in Multiple Solid Tumors

THOMSON REUTERS
·
Aug 18

Akari Therapeutics Says AKTX-101 Shows Anti-Tumor Activity in Preclinical Urothelial Cancer Models

Reuters
·
Aug 18

European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

MT Newswires Live
·
Aug 17

European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading

MT Newswires Live
·
Aug 14

UK's Akari Therapeutics Q2 Net Loss Widens on Higher R&D for AKTX-101

Reuters
·
Aug 14

Akari Therapeutics PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of Aktx-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform

THOMSON REUTERS
·
Aug 14

Press Release: Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform

Dow Jones
·
Aug 14